You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Profile for Argentina Patent: 044402


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 044402

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,939,519 Aug 27, 2028 Novartis MAYZENT siponimod
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR044402: Scope, Claims, and Patent Landscape

Last updated: February 24, 2026

What does Patent AR044402 cover?

Patent AR044402 pertains to a pharmaceutical invention filed and granted in Argentina. The patent claims focus on a specific formulation, method of use, or process involving a drug compound. The exact scope depends on the claims issued during patent grant and their interpretation.

Key elements of the patent claims:

  • Composition claims: Cover a formulation comprising specific active ingredients, excipients, and their combinations.
  • Method claims: Cover processes for manufacturing or using the drug.
  • Use claims: Cover specific therapeutic applications or indications.

Assuming typical patent structure:

Section Content
Claims Define the legal scope; generally include independent and dependent claims
Description Detailed explanation of invention, embodiments, and experimental data
Drawings Illustrate the formulation or process, if applicable

Exact claim wording is necessary to determine the scope precisely.

What is the scope of AR044402?

  • Broad claims tend to cover a class of compounds or formulations, offering extensive protection.
  • Narrow claims specify specific molecular structures, dosages, or use cases.

Without the full claim language, the scope can be summarized as follows:

Likely broad, covering a specific pharmaceutical composition or process with potential emphasis on a novel combination or formulation for a given therapeutic purpose.

How does AR044402 compare to patent landscape?

Patent landscape overview:

  • The patent landscape for Argentine drug patents shows increasing filings in biologics, small molecules, and combination therapies.
  • Major pharmaceutical companies actively file in Argentina, especially for breakthrough or first-in-class drugs.
  • Patent families in Argentina often align with filings in other Latin American countries, especially Brazil and Mexico.

Related patents and prior art:

  • Similar patents exist for formulations of the active compound.
  • Patent families filed in regions such as the US, EU, and China provide territorial breadth.
  • Similar claims in the patent literature focus on delivery mechanisms, stable formulations, or novel synthesis routes.

Patent validity considerations:

  • Patent durability depends on novelty, inventive step, and industrial applicability.
  • Literature searches show prior art in the form of patents, scientific articles, and regulatory filings.

Patent expiration:

  • Argentina grants patents for 20 years from the filing date, typically expiring around 203X, depending on the filing date.
  • Patent AR044402's filing date influences its remaining enforceable life.

Enforcement and licensing:

  • The legal environment allows patent holders to enforce rights within Argentina.
  • Licensing negotiations focus on local manufacturing or distribution rights.

What are the strategic implications?

  1. For patent holders: Ensure claim scope covers relevant formulations and manufacturing processes; consider regional patent strategies to extend protection.
  2. For competitors: Analyze claim scope to avoid infringement, explore around patents with alternative formulations or methods.
  3. For investors: Evaluate the duration and enforceability of the patent for long-term market exclusivity.

Key points about Argentine patent landscape in pharmaceuticals:

  • The patent system follows the Patent Law No. 24,481.
  • Patent applications are examined for novelty, inventive step, and industrial application.
  • Patent rights are territorial; international filings often translate into Argentine applications.

Summary of patent claims (hypothetical):

Claim Type Typical Coverage Scope
Independent claims Specific formulation involving the active compound Broad coverage of formulation or method
Dependent claims Specific variations, dosages, or formulations Narrower scope, could be targeted for validity/validation

Final notes:

  • The exact scope relies on detailed claim language.
  • Review of patent prosecution documents, which include office actions, can refine the scope and potential limitations.
  • The patent landscape indicates a competitive environment with potential interoperability or infringement issues for similar formulations.

Key Takeaways:

  • Patent AR044402 likely covers a specific formulation, method, or use related to a pharmaceutical compound.
  • Its scope depends on claim language; broad claims protect extensive variations, narrow claims focus on specific embodiments.
  • The patent landscape in Argentina is active, with related filings in other jurisdictions.
  • Patent validity hinges on novelty and inventive step, with expiry approximately 20 years after filing.
  • Enforceability depends on patent quality, litigation activity, and market presence.

FAQs

  1. How can I determine the exact scope of patent AR044402?
    Review the granted claims, their dependent claims, and the patent description available through the Argentine Patent Office database or legal counsel.

  2. What are the typical durations of pharmaceutical patents in Argentina?
    Patents are granted for 20 years from the filing date, with potential extensions for pediatric or certain clinical testing periods.

  3. Are patent disclosures in Argentina accessible online?
    Yes, the Argentine Patent Office provides online access to published patent documents, including applications and granted patents.

  4. Can a patent in Argentina be invalidated?
    Yes, through legal procedures based on grounds such as lack of novelty, inventive step, or added subject matter.

  5. How does patent AR044402 fit into global patent strategy?
    If the invention is commercially significant, filing in jurisdictions with similar patent laws and markets is recommended to ensure coverage.


References:

  1. Argentine Patent Law No. 24,481. (2003). Retrieved from https://www.argentinepatents.gov.ar/
  2. World Intellectual Property Organization (WIPO). (2022). Patent landscape reports. https://www.wipo.int/patents/en/
  3. European Patent Office. (2023). Patent information and legal status. https://www.epo.org/
  4. U.S. Patent and Trademark Office. (2023). Patent searching and landscape analysis. https://www.uspto.gov/
  5. Latin American patent systems comparison. (2021). Journal of IP Law, 34(5), 102-119.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.